California 2021-2022 Regular Session

California Assembly Bill AB1618

Introduced
1/6/22  
Introduced
1/6/22  
Refer
1/14/22  
Refer
1/14/22  
Report Pass
3/8/22  
Report Pass
3/8/22  
Refer
3/9/22  
Refer
3/9/22  
Report Pass
3/23/22  
Report Pass
3/23/22  
Refer
3/23/22  
Refer
3/23/22  
Refer
4/6/22  
Refer
4/6/22  
Report Pass
5/19/22  
Report Pass
5/19/22  
Engrossed
5/25/22  
Engrossed
5/25/22  
Refer
5/26/22  
Refer
5/26/22  
Refer
6/1/22  
Refer
6/1/22  
Report Pass
6/9/22  
Report Pass
6/9/22  
Refer
6/13/22  
Refer
6/13/22  

Caption

Alzheimer’s disease.

Impact

The bill represents a significant shift in how California approaches public health concerning Alzheimer's disease. By establishing a dedicated office and program, AB 1618 aims to empower local health jurisdictions to develop tailored initiatives that respond to the unique needs of their communities. This could lead to better resource allocation and improved health outcomes for individuals affected by Alzheimer's and dementia. The one-time grant funding intends to foster community involvement and strategic public-private partnerships to effectively tackle the growing prevalence of these disorders, promoting evidence-based practices throughout the state.

Summary

Assembly Bill 1618, introduced by Assembly Member Aguiar-Curry, aims to enhance the response to Alzheimer's disease and related disorders in California. The bill seeks to establish the Office of the Healthy Brain Initiative within the State Department of Public Health, tasked with coordinating all activities related to Alzheimer's and implementing strategies outlined in the national Healthy Brain Initiative. One significant aspect of this legislation is the provision for grant funding to local health jurisdictions to support local initiatives focused on education, public health partnerships, workforce training, and effective interventions for Alzheimer's disease.

Sentiment

Overall, the sentiment surrounding AB 1618 is positive, particularly among healthcare professionals and advocates for those with Alzheimer's disease. Supporters argue that the bill will enhance collaboration, improve care quality, and provide structures that can adapt to the increasing demands associated with Alzheimer’s care. However, there are also cautious voices expressing concerns about the adequacy of funding and the potential sustainment of local initiatives after the initial grants are awarded. The success of such an initiative may rely heavily on its long-term viability and support from future legislative budgets.

Contention

A notable point of contention involves the expansion of the Alzheimer's Disease and Related Disorders Advisory Committee, which not only revises existing membership provisions but increases membership to include a broader range of stakeholders such as first responders and primary care physicians. While the intention is to enhance representation and expertise, concerns have been raised regarding the effectiveness of a larger committee in reaching consensus and making timely policy recommendations. Additionally, ensuring the continuation of the programs beyond the initial grant funding remains a critical challenge as the bill moves forward.

Companion Bills

No companion bills found.

Similar Bills

CA AB387

Alzheimer’s disease.

CA AB2680

Alzheimer’s disease.

CA AB2207

State boards and commissions: representatives of older adults.

CA AB820

State boards and commissions: seniors.

CA AB388

Alzheimer’s disease.

CA SB639

Medical professionals: course requirements.

CA SB862

Health.